Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details)

v3.22.2
Net (Loss) Income Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Net (loss) income $ (22,195,576) $ (14,177,830) $ (6,380,006) $ (2,692,866) $ (2,845,981) $ 17,227,701 $ (42,753,412) $ 11,688,854
Basic weighted average common shares outstanding 80,088,431     79,729,370     80,054,594 75,054,871
Common stock purchase warrants               499,783
Total net effect of dilutive instruments               7,752,285
Diluted weighted average common shares outstanding 80,088,431     79,729,370     80,054,594 82,807,156
Net (loss) income per basic common share outstanding $ (0.28)     $ (0.03)     $ (0.53) $ 0.16
Net (loss) income per diluted common share outstanding $ (0.28)     $ (0.03)     $ (0.53) $ 0.14
Stock Options [Member]                
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Stock options and appreciation rights               7,208,123
Stock Appreciation Rights (SARs) [Member]                
Schedule of Earnings Per Share, Basic and Diluted [Line Items]                
Stock options and appreciation rights               44,379